Year 2016 -
June 29, 2016
IPA Meeting with the FDA: Quality Forum Update, Washington DC.
May 13, 2016
Presentation to IGDRP: Licensing of Generic Products: Needs and Expectation of Industry, Strasbourg.
January 29, 2021
IPA Submission – USTR Special 301 Report
January 25, 2021
IPA Employee Safety Initiatives Report
August 20, 2021
Generic & biosimilar industry to focus on expanding reach through emerging and traditional modalities: Expert
August 20, 2021
IP Alliance, CSIR organize 1st Pharmaceutical Innovation Exchange Forum
August 18, 2021
‘Regulators should align to formulate standards for the approval of generic and biosimilar medicines – Sudarshan Jain’
August 17, 2021
COVID-19 and Beyond: Focusing on a Patient-centric Culture
August 15, 2021
Scripting independent India’s pharma industry journey from non-existent to a world leader
August 6, 2021
IGBA focusing to promote enabling regulatory environment for generic and biosimilar industry
July 27, 2021
Industry is ready to embrace Digitalization, Says IGBA
July 22, 2021
‘Everything cannot be locally produced,’ Says IGBA Chair
July 15, 2021
Manufacturing cooperation is key to equitable access of vaccines across countries: Dr. Rajesh Jain
July 7, 2021
IGBA launches whitepaper on global generic and biosimilar medicines industry
June 30, 2021
Global vaccination drive and current challenges
June 23, 2021
Strategic stockpiling of essential drugs a way forward for India to combat Covid-19
June 18, 2021
Covid-19 has highlighted the Indian pharma industry’s potential in transforming into an innovation hub: Sudarshan Jain
June 8, 2021
Difficult way to remove vaccine copyright
June 7, 2021
Covid-19 has unlocked new opportunities for the Indian pharma sector: Sudarshan Jain
June 6, 2021
Learning Never Stops
May 17, 2021
Covid-19 tests Indian pharma’s limits
May 7, 2021
Indian pharma cos welcome patent waivers on COVID vaccines, says tech transfer needed to scale up
May 6, 2021
China halting flights to India could hurt pharma supplies, say companies
April 29, 2021
IPA’s Jain Predicts 3-4 Weeks To Meet Indian Shortages
April 26, 2021
Future-ready supply chains
April 21, 2021
Remdesivir Crunch Is Due To Bad Science, Bad Politics: Ex-president, Indian Medical Association
April 14, 2021
Diverse and resilient supply chain significant for pharma industry: Experts
April 14, 2021
COVID-19 vaccines: India needs to rise
March 28, 2021
Patient-centricity must drive the pharma sector
March 25, 2021
PCI introduces faculty-industry training programme for teachers to make students industry-ready after graduation
March 22, 2021
Teachers should have good knowledge of drug development through exposure to industry practices: Expert
March 19, 2021
Dr Reddy’s On Digitization Amid COVID-19, ‘Lights-Out’ Manufacturing
March 18, 2021
Underlying the challenges and opportunities
March 1, 2021
Pharma stalwarts demystify COVID-19 impact on industry
February 25, 2021
Realisation there in pharma industry to become self-reliant in API production: IPA
February 22, 2021
India Pharmaceutical Forum to focus on patients, Covid-19
February 18, 2021
Pharma is a jewel in India’s crown with long term growth opportunities
January 28, 2021
Innovation and collaboration will help Indian pharma leapfrog in the global value chain: Experts
January 25, 2021
Back to Growth: Pharmaceutical sector overview and interview with Sudarshan Jain, Secretary General, IPA
January 24, 2021
Union Budget 2021: Covid-19 pandemic underlines need for higher allocation for healthcare sector
January 23, 2021
Industry opens bag of expectations for Union Budget 2021-22
January 20, 2021
Drug manufacturers hope new US govt will see them as ‘allies’
July 7, 2021
A Vision for the Global Generic and Biosimilar Medicines Industry Whitepaper
